The International journal on drug policy · 2026
Daily anxiety and depressive symptoms are associated with greater same-day cannabis-alcohol co-use than single-substance use among Black sexual and gender minority people.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Yen-Tyng, Schneider John A, Almirol Ellen, Wiger Ella Remund, Pagkas-Bather Jade, Jiang Yanping, Huh Jimi, Chung Tammy, Duncan Dustin T, Knox Justin
Аннотация
BACKGROUND: Rapidly changing cannabis legalization has contributed to increased cannabis use and co-use of cannabis and alcohol, including among sexual and gender minority people (SGM). Black SGM endure long-standing disparities in comorbidities of substance use, mental health, and other critical health outcomes, yet little is known about cannabis-alcohol co-use and its mental health correlates. This study examined associations of anxiety/depression symptoms with same-day cannabis-alcohol co-use among Black SGM.
METHODS: Data were obtained from the Neighborhoods and Networks Part 2 (N2P2) Study (2022-2024), a cohort of Black SGM aged 16-35 in Chicago, Illinois (n = 617). Participants completed a 14-day ecological momentary assessment (EMA) of cannabis and alcohol use and mental health symptoms. Random-effect multinomial logistic regression models examined relationships of anxiety/depression and same-day cannabis-alcohol co-use.
RESULTS: Across 5729 EMA days from 521 participants who completed ≥1 EMA daily survey, same-day cannabis-alcohol co-use, cannabis-only use, and alcohol-only use occurred on 19.8 %, 36.5 %, and 6.3 % of days, respectively. Elevated daily anxiety and/or depressive symptoms were reported on 20.9 % of days. Participants were more likely to report same-day co-use vs. no use on days with mild (aRR=1.5, 95 % CI: 1.2-1.9) or moderate (aRR=1.9, 95 % CI: 1.4-2.5) daily anxiety and/or depressive symptoms. Compared with single-substance use days, moderate general anxiety/depressive symptoms were more likely to be reported on co-use days (aRR=1.6, 95 % CI: 1.3-2.1).
CONCLUSION: The findings underscore the additive comorbidity of mental health and same-day cannabis-alcohol co-use. Future research should identify subgroups at heightened risk and develop multilevel interventions addressing co-use and mental health among Black SGM.
METHODS: Data were obtained from the Neighborhoods and Networks Part 2 (N2P2) Study (2022-2024), a cohort of Black SGM aged 16-35 in Chicago, Illinois (n = 617). Participants completed a 14-day ecological momentary assessment (EMA) of cannabis and alcohol use and mental health symptoms. Random-effect multinomial logistic regression models examined relationships of anxiety/depression and same-day cannabis-alcohol co-use.
RESULTS: Across 5729 EMA days from 521 participants who completed ≥1 EMA daily survey, same-day cannabis-alcohol co-use, cannabis-only use, and alcohol-only use occurred on 19.8 %, 36.5 %, and 6.3 % of days, respectively. Elevated daily anxiety and/or depressive symptoms were reported on 20.9 % of days. Participants were more likely to report same-day co-use vs. no use on days with mild (aRR=1.5, 95 % CI: 1.2-1.9) or moderate (aRR=1.9, 95 % CI: 1.4-2.5) daily anxiety and/or depressive symptoms. Compared with single-substance use days, moderate general anxiety/depressive symptoms were more likely to be reported on co-use days (aRR=1.6, 95 % CI: 1.3-2.1).
CONCLUSION: The findings underscore the additive comorbidity of mental health and same-day cannabis-alcohol co-use. Future research should identify subgroups at heightened risk and develop multilevel interventions addressing co-use and mental health among Black SGM.